Approved Hospital Formulary
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:

glycopyrrolate

glycopyrrolate
Drug Name Form Strength Notes
Glycopyrrolate SOLUTION, INJECTABLE 0.2 mg/mL
Glycopyrrolate TABLET, ORAL 1 mg
Glycopyrrolate TABLET, ORAL 2 mg
glycopyrronium
Robinul
Seebri Neohaler CAPSULE, INHALATION 15.6 mcg


Additional Information:

Glycopyrrolate bromide DPI (Seebri Neohaler) is a Non-Formulary agent. All orders will be automatically changed to Tiotropium (SPIRIVA Respimat). See Therapeutic Interchange.


Last updated: Mar. 31, 2022







This site is intended for the staff of Legacy Health.
While others may view accessible pages, Legacy Health makes no warranty, express or implied,
as to the use of this information outside of Legacy Health.